Lavipharm SA. announces that, according to the article 292 paragraph 4 of the Athens Stock Exchange Regulation, the annual analyst briefing took place today, Friday, June 6th, at the Company's premises. The presentation is available for the information of the Investors Community on the website of both Lavipharm and the Athens Stock Exchange.